Aviance Capital Partners LLC Reduces Stock Holdings in CME Group Inc. (NASDAQ:CME)

Aviance Capital Partners LLC lessened its holdings in shares of CME Group Inc. (NASDAQ:CME) by 2.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,410 shares of the financial services provider’s stock after selling 57 shares during the period. Aviance Capital Partners LLC’s holdings in CME Group were worth $531,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CME. Y.D. More Investments Ltd purchased a new position in CME Group during the second quarter valued at approximately $36,000. McClarren Financial Advisors Inc. increased its holdings in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares in the last quarter. Asset Dedication LLC lifted its stake in shares of CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the period. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares in the last quarter. Finally, Bank & Trust Co acquired a new stake in CME Group during the second quarter valued at $76,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Timothy S. Bitsberger sold 1,000 shares of CME Group stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the completion of the sale, the director now directly owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. The trade was a 8.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 15.89 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,621 shares of company stock valued at $3,441,063. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

CME has been the subject of several recent analyst reports. Piper Sandler lifted their price target on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. The Goldman Sachs Group increased their target price on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. TD Cowen started coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target for the company. Oppenheimer increased their price objective on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Finally, Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus target price of $224.47.

CME Group Stock Up 0.9 %

CME stock opened at $229.66 on Wednesday. CME Group Inc. has a one year low of $190.70 and a one year high of $230.74. The firm has a market cap of $82.76 billion, a PE ratio of 24.15, a PEG ratio of 5.20 and a beta of 0.55. The firm’s 50 day moving average price is $223.02 and its 200-day moving average price is $210.69. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.25 EPS. On average, equities research analysts anticipate that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.00%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.